Lupus Management: Monitoring and Treating to Minimize Organ Damage and Optimize Outcomes

Lupus Management: Monitoring and Treating to Minimize Organ Damage and Optimize Outcomes is organized by RedMedEd.

Release Date: 07/15/2022
Expiration Date:  07/15/2023

Overview:
Management of systemic lupus erythematosus (SLE) is complicated by its variable and often subtle presentation, yet prompt diagnosis and treatment is essential to preventing organ damage and its consequent morbidity and mortality. Hydroxychloroquine and glucocorticoids are options for achieving SLE control, though long-term use of the latter is associated with dose-related damage. Fortunately, newer targeted agents are providing clinicians with options for minimizing glucocorticoid use. Additionally, disease activity monitoring has proven valuable in minimizing flares and limiting organ damage.

This activity uses two virtual patient cases to review current recommendations for SLE management, including the use of new targeted therapies and strategies for monitoring disease activity, adjusting treatment when necessary, and optimizing patient outcomes.

Learning Objectives:
Upon completion of this activity, participants should be better able to:
• Monitor disease activity to promptly recognize exacerbations (flares)
• Employ regular monitoring to maximize disease control, minimize medication side effects, prevent SLE-related organ damage, inform clinical decision-making, and adjust therapy as needed
• Apply the most current safety and efficacy data when using new and emerging targeted SLE therapies.